NRC Health NRC
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- +26.96%
- 1 year
- +81.91%
- Open
- 23.64
- Prev close
- 23.49
- Mkt cap
- 505.71M
- Vol
- 86.22K
- Avg vol
- 115.22K
- EPS
- 0.27
- P/E
- 88.26
- Div yield
- 2.80%
More statistics
- Low
- 23.47
- High
- 24.01
- Forward P/E
- 15.38
- Beta
- 0.53
- Short ratio
- 4.02
- Inst. own
- 52.02%
- Dividend
- 0.48
- Ex-div date
- Dec 26, 2024
- Earnings
- Feb 11, 2025
- 50-d avg
- 18.96
- 200-d avg
- 25.47
- 1y target
- 0.00
5D chart
Signals (93)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Oct 30, 3:55 PM | 2 days ago |
| SMA: Bearish | Oct 30, 3:30 PM | 2 days ago |
| SMA: Bullish | Oct 30, 3:20 PM | 2 days ago |
| SMA: Bullish | Oct 30, 2:50 PM | 2 days ago |
| SMA: Bearish | Oct 30, 2:20 PM | 2 days ago |
| SMA: Bearish | Oct 30, 2:20 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 2:20 PM | 2 days ago |
| SMA: Bullish | Oct 30, 2:10 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 2:10 PM | 2 days ago |
| SMA: Bearish | Oct 30, 2:05 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 2:05 PM | 2 days ago |
| SMA: Bullish | Oct 30, 1:05 PM | 2 days ago |
| SMA: Bearish | Oct 30, 1:00 PM | 2 days ago |
| SMA: Bullish | Oct 30, 12:10 PM | 2 days ago |
| SMA: Bearish | Oct 30, 11:45 AM | 2 days ago |
| SMA: Bullish | Oct 30, 11:30 AM | 2 days ago |
| SMA: Bearish | Oct 30, 11:25 AM | 2 days ago |
| SMA: Bullish | Oct 30, 10:35 AM | 2 days ago |
| SMA: Bullish | Oct 30, 10:35 AM | 2 days ago |
| SMA: Bearish | Oct 30, 10:25 AM | 2 days ago |
| SMA: Bearish | Oct 30, 10:15 AM | 2 days ago |
| SMA: Bullish | Oct 30, 9:40 AM | 2 days ago |
| MACD: Buy Signal | Oct 30, 9:40 AM | 2 days ago |
| SMA: Bullish | Oct 30, 9:30 AM | 2 days ago |
| SMA: Bearish | Oct 29, 2:25 PM | 3 days ago |
| SMA: Bullish | Oct 29, 2:10 PM | 3 days ago |
| SMA: Bearish | Oct 29, 2:05 PM | 3 days ago |
| SMA: Bullish | Oct 29, 1:55 PM | 3 days ago |
| SMA: Bearish | Oct 29, 1:40 PM | 3 days ago |
| SMA: Bearish | Oct 29, 1:40 PM | 3 days ago |
| SMA: Bullish | Oct 29, 1:20 PM | 3 days ago |
| SMA: Bullish | Oct 29, 1:20 PM | 3 days ago |
| SMA: Bearish | Oct 29, 12:55 PM | 3 days ago |
| SMA: Bullish | Oct 29, 12:50 PM | 3 days ago |
| SMA: Bearish | Oct 29, 12:40 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 12:10 PM | 3 days ago |
| SMA: Bearish | Oct 29, 12:05 PM | 3 days ago |
| RSI: Overbought | Oct 29, 11:00 AM | 3 days ago |
| SMA: Bullish | Oct 28, 3:40 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 3:40 PM | 4 days ago |
| SMA: Bullish | Oct 28, 3:15 PM | 4 days ago |
| SMA: Bearish | Oct 28, 2:15 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 2:15 PM | 4 days ago |
| SMA: Bullish | Oct 28, 1:50 PM | 4 days ago |
| SMA: Bearish | Oct 28, 1:45 PM | 4 days ago |
| RSI: Overbought | Oct 28, 1:30 PM | 4 days ago |
| SMA: Bullish | Oct 28, 12:15 PM | 4 days ago |
| SMA: Bearish | Oct 28, 12:00 PM | 4 days ago |
| SMA: Bullish | Oct 28, 11:55 AM | 4 days ago |
| SMA: Bearish | Oct 28, 11:50 AM | 4 days ago |
| MACD: Buy Signal | Oct 28, 11:50 AM | 4 days ago |
| SMA: Bullish | Oct 28, 11:45 AM | 4 days ago |
| SMA: Bearish | Oct 28, 11:30 AM | 4 days ago |
| SMA: Bullish | Oct 28, 11:25 AM | 4 days ago |
| SMA: Bullish | Oct 28, 11:25 AM | 4 days ago |
| SMA: Bearish | Oct 28, 11:10 AM | 4 days ago |
| MACD: Sell Signal | Oct 28, 10:25 AM | 4 days ago |
| SMA: Bearish | Oct 28, 10:10 AM | 4 days ago |
| RSI: Overbought | Oct 28, 9:35 AM | 4 days ago |
| SMA: Bullish | Oct 28, 9:30 AM | 4 days ago |
| SMA: Bullish | Oct 28, 9:30 AM | 4 days ago |
| SMA: Bearish | Oct 27, 3:55 PM | 5 days ago |
| SMA: Bullish | Oct 27, 3:45 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 3:45 PM | 5 days ago |
| SMA: Bearish | Oct 27, 11:35 AM | 5 days ago |
| SMA: Bearish | Oct 27, 11:35 AM | 5 days ago |
| SMA: Bullish | Oct 27, 11:00 AM | 5 days ago |
| SMA: Bullish | Oct 27, 11:00 AM | 5 days ago |
| SMA: Bullish | Oct 27, 10:35 AM | 5 days ago |
| SMA: Bearish | Oct 27, 10:25 AM | 5 days ago |
| SMA: Bearish | Oct 27, 10:25 AM | 5 days ago |
| SMA: Bullish | Oct 27, 10:10 AM | 5 days ago |
| SMA: Bullish | Oct 27, 10:10 AM | 5 days ago |
| SMA: Bearish | Oct 27, 9:50 AM | 5 days ago |
| SMA: Bearish | Oct 27, 9:50 AM | 5 days ago |
| MACD: Sell Signal | Oct 27, 9:50 AM | 5 days ago |
| SMA: Bullish | Oct 27, 9:45 AM | 5 days ago |
| SMA: Bullish | Oct 27, 9:45 AM | 5 days ago |
| SMA: Bearish | Oct 27, 9:40 AM | 5 days ago |
| SMA: Bearish | Oct 27, 9:40 AM | 5 days ago |
| MACD: Buy Signal | Oct 27, 9:30 AM | 5 days ago |
| RSI: Overbought | Oct 27, 9:30 AM | 5 days ago |
| SMA: Bullish | Oct 26, 3:55 PM | 6 days ago |
| SMA: Bullish | Oct 26, 3:30 PM | 6 days ago |
| SMA: Bearish | Oct 26, 3:25 PM | 6 days ago |
| SMA: Bullish | Oct 26, 2:55 PM | 6 days ago |
| SMA: Bearish | Oct 26, 2:35 PM | 6 days ago |
| SMA: Bullish | Oct 26, 2:30 PM | 6 days ago |
| SMA: Bearish | Oct 26, 1:05 PM | 6 days ago |
| SMA: Bullish | Oct 26, 12:55 PM | 6 days ago |
| SMA: Bearish | Oct 26, 12:50 PM | 6 days ago |
| SMA: Bullish | Oct 26, 12:15 PM | 6 days ago |
| SMA: Bearish | Oct 26, 11:55 AM | 6 days ago |
News
2 days ago globenewswire.com
NRC Completes Landmark Safety Review of X-energy's Xe-100 SMR
Final Safety Evaluation Report formally completes NRC safety review Marks completion of both primary reviews required for Construction Permit approval Establishes regulatory precedent to support more…
2 days ago newsfilecorp.com
RETRANSMISSION: Manganese X Energy Provides Battery Hill High-Purity Manganese Sample for NRC-Led POSCO LMR Cathode Research Project
Montreal, Quebec--(Newsfile Corp. - October 30, 2026) - Manganese X Energy Corp. (TSXV: MN) (FSE: 9SC) (TRADEGATE: 9SC) (OTCQB: MNXXF) ("Manganese X" or the "Company") is pleased to announce that it…
3 days ago newsfilecorp.com
Manganese X Energy Provides Battery Hill High-Purity Manganese Sample for NRC-Led POSCO LMR Cathode Research Project
Montreal, Quebec--(Newsfile Corp. - October 30, 2026) - Manganese X Energy Corp. (TSXV: MN) (FSE: 9SC) (TRADEGATE: 9SC) (OTCQB: MNXXF) ("Manganese X" or the "Company") is pleased to announce that it…
-
4 days ago benzinga.com
Citizens Maintains Market Outperform on NRC Health, Raises Price Target to $27
Citizens analyst Constantine Davides maintains NRC Health (NASDAQ:NRC) with a Market Outperform and raises the price target from $26 to $27.
5 days ago marketbeat.com
National Research Q3 Earnings Call Highlights
National Research NASDAQ: NRC, which operates as NRC Health, reported third-quarter revenue growth of 11% to $38 million as a large customer implementation went live on schedule and contributed…
5 days ago benzinga.com
National Research Q3 2026 Earnings Call Transcript
National Research (NASDAQ:NRC) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to…
-
5 days ago benzinga.com
National Research Q3 Adj. EPS $0.21, Inline, Sales $38.399M Beat $35.800M Estimate
National Research (NASDAQ:NRC) reported quarterly earnings of $0.21 per share which met the analyst consensus estimate. This is a 8.7 percent decrease over earnings of $0.23 per share from the same…
5 days ago businesswire.com
NRC Health Announces Third Quarter 2026 Results
LINCOLN, Neb.--(BUSINESS WIRE)--NRC Health (NASDAQ: NRC), a leader in healthcare experience improvement solutions, today announced results for the third quarter 2026. “We delivered a strong third…
6 days ago businesswire.com
NRC Health Launches nQuire Pro, Extending the Reach of Patient-Experience Teams
LINCOLN, Neb.--(BUSINESS WIRE)-- #HealthcareAccess--NRC Health, a recognized leader in healthcare experience management, today announced the launch of nQuire Pro, a conversational analytics tool…
1 week ago fool.com
NuScale Power Trades Below $6 With the Only NRC-Certified Small Modular Reactor Design. Here's Why That Still Isn't Enough.
NuScale's small modular reactor has design approval from the U.S. Nuclear Regulatory Commission. The upstart company will need to secure a binding power purchase agreement in the near future.
1 week ago globenewswire.com
Terra Innovatum Advances SOLO™ Construction Permit Application and Reactor Procurement, Reaffirms Fully Funded Path to 2027 First-Of-A-Kind Deployment
Company shares 12 of 18 draft PSAR chapters with NRC for readiness review, targets remaining six by October 30 Major reactor components secured or under procurement as Company advances toward fully…
-
1 week ago benzinga.com
NRC Health Appoints CEO Trent Green As Interim Principal Financial Officer
On October 14, 2026, the board of directors of NRC Health, a Delaware corporation (the "Company"), designated Trent Green, the Company’s Chief Executive Officer, to serve as the Company’s interim…
2 weeks ago defenseworld.net
Head-To-Head Comparison: Phreesia (NYSE:PHR) & National Research (NASDAQ:NRC)
National Research (NASDAQ: NRC - Get Free Report) and Phreesia (NYSE: PHR - Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will compare the two…
2 weeks ago businesswire.com
New NRC Health Research Reveals What Sets High-Performing Health Systems Apart: Turning Patient Feedback Into Action
LINCOLN, Neb.--(BUSINESS WIRE)-- #ExperienceManagementEverywhere--Healthcare organizations have more patient feedback, performance dashboards, and experience data at their fingertips than ever…
2 weeks ago defenseworld.net
National Research (NASDAQ:NRC) Stock Price Crosses Above 200 Day Moving Average – Should You Sell?
National Research Corporation (NASDAQ: NRC - Get Free Report) passed above its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of $19.91 and traded as high…
2 weeks ago globenewswire.com
NANO Nuclear's KRONOS MMR™ Program Advancing Through U.S. NRC Review with the University of Illinois Urbana-Champaign
U. of I. and NANO Nuclear have continued technical engagement with the NRC through the ongoing audit process following formal acceptance of the KRONOS MMR ™ Construction Permit Application for review
2 weeks ago newsfilecorp.com
NANO Nuclear's KRONOS MMR(TM) Program Advancing Through U.S. NRC Review with the University of Illinois Urbana-Champaign
U. of I. and NANO Nuclear have continued technical engagement with the NRC through the ongoing audit process following formal acceptance of the KRONOS MMR™ Construction Permit Application for review…
3 weeks ago defenseworld.net
Head to Head Survey: National Research (NASDAQ:NRC) vs. Teladoc Health (NYSE:TDOC)
Teladoc Health (NYSE: TDOC - Get Free Report) and National Research (NASDAQ: NRC - Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will contrast the two…
1 month ago newsfilecorp.com
NANO Nuclear Energy Advances Vertical Integration Strategy by Signing Definitive Agreement to Acquire Strategic NRC-Licensed U.S. Nuclear Fuel Processing Assets
Acquisition would provide NANO Nuclear with strategically valuable NRC-licensed fuel cycle assets and optionality to pursue domestic nuclear fuel cycle activities, independently or in collaboration…
1 month ago globenewswire.com
Former U.S. NRC Commissioner and U.S. DOE Nuclear Chief William D. Magwood, IV to Join newcleo's Board of Directors in January 2027
Magwood's experience negotiating nuclear policy with dozens of governments will give newcleo invaluable insight as it licenses its reactor technology in new markets Magwood's experience negotiating…
1 month ago zacks.com
NRC Health Trades at a Discount: Should You Buy, Sell or Hold?
NRC's rising recurring contract value, expanding sales pipeline and AI-enabled tools support revenue visibility and potential margin improvement.
1 month ago etftrends.com
New Momentum in the Nuclear Fuel Chain
The nuclear renaissance requires a fuel chain that can support the ambitions of the reactor development companies. The simplest example is a car and its gas station.
2 months ago gurufocus.com
KLAS First Look: NRC Health Rounding Earns 91.6 Overall Performance Score
Healthcare leaders are under growing pressure to improve patient experience, support care teams, strengthen safety, and act on feedback faster. A new [url="]KLA
2 months ago businesswire.com
NRC Health Announces 2026 Award Winners Recognizing Excellence Across Healthcare
LINCOLN, Neb.--(BUSINESS WIRE)-- #HealthcareConsumerLoyalty--NRC Health today announced the winners of its 2026 awards program, recognizing hospitals, health systems, medical groups, and specialty…
2 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Liminatus Pharma (NASDAQ:LIMN) stock moved upwards by 55.9% to $0.17 during Thursday's pre-market session. The company's market cap stands at $7.2 million. LENSAR (NASDAQ:LNSR) shares…
-
2 months ago benzinga.com
On Aug 7, Shane Harrison, CFO of NRC Health, Tendered Resignation From The Co.; Resignation Effective As August 28, 2026
On August 7, 2026, Shane Harrison, Chief Financial Officer and principal financial officer of NRC Health, a Delaware corporation (the "Company"), tendered his resignation from the Company in order to…
-
3 months ago benzinga.com
Citizens Maintains Market Outperform on NRC Health, Raises Price Target to $26
Citizens analyst Constantine Davides maintains NRC Health (NASDAQ:NRC) with a Market Outperform and raises the price target from $23 to $26.
-
3 months ago benzinga.com
National Research Q2 Adj. EPS $0.31 Beats $0.14 Estimate, Sales $35.392M Beat $34.900M Estimate
National Research (NASDAQ:NRC) reported quarterly earnings of $0.31 per share which beat the analyst consensus estimate of $0.14 by 121.43 percent. This is a 10.71 percent increase over earnings of…
-
4 months ago benzinga.com
Citizens Initiates Coverage On NRC Health with Market Outperform Rating, Announces Price Target of $23
Citizens analyst Constantine Davides initiates coverage on NRC Health (NASDAQ:NRC) with a Market Outperform rating and announces Price Target of $23.
7 months ago benzinga.com
Nio, Zevra Therapeutics, Vertex Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
Dow Jones index up 200 points on Tuesday, NIO Inc. gained following better-than-expected financial results and Capricor Therapeutics announced a new PDUFA date for Deramiocel BLA.
-
7 months ago benzinga.com
National Research Announces $60M Buyback Plan Through March 31, 2028
National Research Corporation, dba NRC Health, (NASDAQ: NRC), a leader in healthcare experience improvement solutions, today announced that its Board of Directors authorized a stock repurchase…
-
8 months ago benzinga.com
NRC Health Surpasses $152M In Total Recurring Contract Value As Of March 4, 2026, Increasing 13% YoY
National Research Corporation, dba NRC Health, (NASDAQ:NRC), a leader in healthcare experience improvement solutions, today announced that it has surpassed $152 million in Total Recurring Contract…
9 months ago benzinga.com
Transcript: National Research Q4 2025 Earnings Conference Call
Transcript: National Research Q4 2025 Earnings Conference Call
-
9 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
12 Health Care Stocks Moving In Tuesday's Intraday Session
9 months ago benzinga.com
Earnings Scheduled For February 3, 2026
Earnings Scheduled For February 3, 2026
-
11 months ago benzinga.com
NRC Health Enters Partnership With BJC Health System To Enhance And Unify Patient And Employee Experiences Across BJC's Hospitals, Clinics, And Academic Partners
NRC Health, the leader in healthcare experience management, is proud to announce a new partnership with BJC Health System, one of the nation's largest nonprofit integrated healthcare delivery…
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
12 Health Care Stocks Moving In Tuesday's Intraday Session
-
1 year ago benzinga.com
National Research Q3 Adj. EPS $0.23 Down From $0.25 YoY, Sales $34.819M Down From $35.819M YoY
National Research (NASDAQ:NRC) reported quarterly earnings of $0.23 per share. This is a 8 percent decrease over earnings of $0.25 per share from the same period last year. The company reported…
1 year ago benzinga.com
Earnings Scheduled For October 27, 2025
Companies Reporting Before The Bell • Keurig Dr Pepper (NASDAQ:KDP) is projected to report quarterly earnings at $0.54 per share on revenue of $4.15 billion.
-
2 years ago benzinga.com
Earnings Scheduled For February 13, 2024
Companies Reporting Before The Bell • LCI Indus (NYSE:LCII) is likely to report quarterly earnings at $0.18 per share on revenue of $838.27 million.
-
2 years ago benzinga.com
Earnings Scheduled For November 7, 2023
Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.
-
3 years ago benzinga.com
Earnings Scheduled For August 1, 2023
Companies Reporting Before The Bell • Toyota Motor (NYSE:TM) is estimated to report earnings for its first quarter. • BP (NYSE:BP) is projected to report quarterly earnings at $1.21 per share on…
-
3 years ago benzinga.com
Earnings Scheduled For February 14, 2023
Companies Reporting Before The Bell • WESCO International (NYSE:WCC) is projected to report quarterly earnings at $3.79 per share on revenue of $5.37 billion.
-
4 years ago benzinga.com
Earnings Scheduled For November 1, 2022
Companies Reporting Before The Bell • BP (NYSE:BP) is estimated to report quarterly earnings at $2.07 per share on revenue of $64.76 billion.
-
4 years ago benzinga.com
Earnings Scheduled For August 2, 2022
Companies Reporting Before The Bell • Ferrari (NYSE:RACE) is expected to report quarterly earnings at $1.27 per share on revenue of $1.22 billion.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
During Thursday, 351 stocks hit new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Wednesday
During Wednesday's trading, 435 companies set new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 211 companies set new 52-week lows.
-
4 years ago benzinga.com
Earnings Scheduled For May 3, 2022
Companies Reporting Before The Bell • Kiniksa Pharmaceuticals (NASDAQ:KNSA) is projected to report earnings for its first quarter.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
During Thursday, 849 stocks hit new 52-week lows.